{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["Discussion"], "sentence": "Discussion", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S2", "tokens": ["This", "study", "defines", "the", "oncogenic", "properties", "of", "LMP1", "in", "promoting", "B", "cell", "lymphomagenesis", "."], "sentence": "This study defines the oncogenic properties of LMP1 in promoting B cell lymphomagenesis .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "LMP1", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S3", "tokens": ["LMP1", "transgenic", "mice", "have", "a", "higher", "incidence", "of", "lymphoma", "[", "26", "]", "and", "the", "progression", "to", "lymphoma", "correlates", "with", "higher", "expression", "levels", "of", "LMP1", "(", "Figure", "1A", "and", "1B", ")", ",", "suggesting", "that", "LMP1", "is", "directly", "involved", "in", "tumor", "development", "."], "sentence": "LMP1 transgenic mice have a higher incidence of lymphoma [ 26 ] and the progression to lymphoma correlates with higher expression levels of LMP1 ( Figure 1A and 1B ) , suggesting that LMP1 is directly involved in tumor development .", "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "higher", "start": 19, "end": 19}, "arguments": [{"entity_id": "T98", "text": "expression", "role": "Theme"}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 20, "end": 20}, "arguments": [{"entity_id": "T3", "text": "LMP1", "role": "Theme"}]}], "entity_mentions": [{"id": "T2", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T3", "text": "LMP1", "entity_type": "Protein", "start": 23, "end": 23}, {"id": "T4", "text": "LMP1", "entity_type": "Protein", "start": 33, "end": 33}, {"id": "T97", "text": "higher", "entity_type": "Positive_regulation", "start": 19, "end": 19}, {"id": "T98", "text": "expression", "entity_type": "Gene_expression", "start": 20, "end": 20}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S4", "tokens": ["Table", "1", "summarizes", "the", "biological", "and", "molecular", "properties", "that", "were", "identified", "in", "wild-type", "and", "LMP1", "transgenic", "lymphomas", "."], "sentence": "Table 1 summarizes the biological and molecular properties that were identified in wild-type and LMP1 transgenic lymphomas .", "event_mentions": [], "entity_mentions": [{"id": "T5", "text": "LMP1", "entity_type": "Protein", "start": 14, "end": 14}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S5", "tokens": ["Although", "many", "of", "the", "molecular", "properties", "studied", "were", "similar", "between", "wild-type", "and", "LMP1", "transgenic", "lymphomas", ",", "there", "were", "distinguishing", "biological", "properties", ",", "namely", "the", "ability", "of", "LMP1", "transgenic", "lymphomas", "to", "induce", "higher", "levels", "of", "survival", "and", "proliferation", "."], "sentence": "Although many of the molecular properties studied were similar between wild-type and LMP1 transgenic lymphomas , there were distinguishing biological properties , namely the ability of LMP1 transgenic lymphomas to induce higher levels of survival and proliferation .", "event_mentions": [], "entity_mentions": [{"id": "T6", "text": "LMP1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T7", "text": "LMP1", "entity_type": "Protein", "start": 26, "end": 26}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S6", "tokens": ["Interestingly", ",", "although", "LMP1", "transgenic", "mice", "develop", "lymphomas", "in", "the", "same", "B-1a", "cell", "type", "as", "spontaneous", "wild-type", "lymphomas", "(", "Figure", "2", ")", ",", "some", "signaling", "effects", "induced", "by", "LMP1", "may", "explain", "the", "enhanced", "promotion", "to", "lymphomagenesis", "."], "sentence": "Interestingly , although LMP1 transgenic mice develop lymphomas in the same B-1a cell type as spontaneous wild-type lymphomas ( Figure 2 ) , some signaling effects induced by LMP1 may explain the enhanced promotion to lymphomagenesis .", "event_mentions": [], "entity_mentions": [{"id": "T8", "text": "LMP1", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T9", "text": "LMP1", "entity_type": "Protein", "start": 28, "end": 28}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S7", "tokens": ["Since", "CD40", "-", "deficient", "mice", "have", "decreased", "numbers", "of", "IgMhighIgDlow", "cells", ",", "a", "phenotype", "associated", "with", "B-1", ",", "marginal", "zone", ",", "and", "memory", "B", "cells", ",", "the", "mimicry", "of", "CD40", "signaling", "by", "LMP1", "could", "possibly", "contribute", "to", "the", "expansion", "of", "B-1", "cells", "[", "20", "]", "."], "sentence": "Since CD40 - deficient mice have decreased numbers of IgMhighIgDlow cells , a phenotype associated with B-1 , marginal zone , and memory B cells , the mimicry of CD40 signaling by LMP1 could possibly contribute to the expansion of B-1 cells [ 20 ] .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 3, "end": 3}, "arguments": [{"entity_id": "T10", "text": "CD40", "role": "Theme"}]}], "entity_mentions": [{"id": "T10", "text": "CD40", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T11", "text": "CD40", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T12", "text": "LMP1", "entity_type": "Protein", "start": 32, "end": 32}, {"id": "T99", "text": "deficient", "entity_type": "Negative_regulation", "start": 3, "end": 3}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S8", "tokens": ["It", "is", "noteworthy", "that", "expression", "of", "LMP1", "in", "transgenic", "mice", "has", "been", "shown", "to", "inhibit", "the", "formation", "of", "GCs", "[", "23", ",", "49", "]", ",", "preventing", "typical", "B-2", "cells", "from", "antigen", "-", "driven", "selection", "and", "expansion", "."], "sentence": "It is noteworthy that expression of LMP1 in transgenic mice has been shown to inhibit the formation of GCs [ 23 , 49 ] , preventing typical B-2 cells from antigen - driven selection and expansion .", "event_mentions": [{"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 4, "end": 4}, "arguments": [{"entity_id": "T13", "text": "LMP1", "role": "Theme"}]}], "entity_mentions": [{"id": "T13", "text": "LMP1", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T100", "text": "expression", "entity_type": "Gene_expression", "start": 4, "end": 4}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S9", "tokens": ["The", "lack", "of", "GC", "reactions", "may", "contribute", "to", "the", "bias", "of", "LMP1", "transgenic", "mice", "towards", "B-1", "cell", "lymphomas", "."], "sentence": "The lack of GC reactions may contribute to the bias of LMP1 transgenic mice towards B-1 cell lymphomas .", "event_mentions": [], "entity_mentions": [{"id": "T14", "text": "LMP1", "entity_type": "Protein", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S10", "tokens": ["Interestingly", ",", "LMP2", "signaling", "also", "favors", "development", "of", "B-1", "cells", ",", "but", "this", "occurs", "in", "the", "absence", "of", "transformation", "."], "sentence": "Interestingly , LMP2 signaling also favors development of B-1 cells , but this occurs in the absence of transformation .", "event_mentions": [], "entity_mentions": [{"id": "T15", "text": "LMP2", "entity_type": "Protein", "start": 2, "end": 2}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S11", "tokens": ["These", "results", "suggest", "that", "the", "mimicry", "of", "B", "cell", "receptor", "signaling", "by", "LMP2", "promotes", "B-1", "cell", "differentiation", "but", "not", "transformation", "[", "24", ",", "50", ",", "51", "]", "."], "sentence": "These results suggest that the mimicry of B cell receptor signaling by LMP2 promotes B-1 cell differentiation but not transformation [ 24 , 50 , 51 ] .", "event_mentions": [], "entity_mentions": [{"id": "T16", "text": "LMP2", "entity_type": "Protein", "start": 12, "end": 12}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S12", "tokens": ["This", "promotion", "of", "B-1", "differentiation", "may", "account", "for", "the", "ability", "of", "LMP2", "to", "exacerbate", "autoimmunity", "and", "bypass", "anergy", "induction", "[", "52", ",", "53", "]", "."], "sentence": "This promotion of B-1 differentiation may account for the ability of LMP2 to exacerbate autoimmunity and bypass anergy induction [ 52 , 53 ] .", "event_mentions": [], "entity_mentions": [{"id": "T17", "text": "LMP2", "entity_type": "Protein", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S13", "tokens": ["In", "contrast", ",", "the", "preponderance", "of", "tumors", "of", "B-1a", "origin", "does", "not", "reflect", "effects", "of", "LMP1", "signaling", "on", "B", "cell", "differentiation", ",", "as", "splenic", "B", "cells", "from", "healthy", "LMP1", "transgenic", "mice", "contain", "similar", "numbers", "of", "B-1", "and", "B-2", "cells", "as", "wild-type", "mice", "."], "sentence": "In contrast , the preponderance of tumors of B-1a origin does not reflect effects of LMP1 signaling on B cell differentiation , as splenic B cells from healthy LMP1 transgenic mice contain similar numbers of B-1 and B-2 cells as wild-type mice .", "event_mentions": [], "entity_mentions": [{"id": "T18", "text": "LMP1", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T19", "text": "LMP1", "entity_type": "Protein", "start": 28, "end": 28}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S14", "tokens": ["In", "support", "of", "this", "lack", "of", "effect", ",", "the", "differentiation", "of", "B-1", "versus", "B-2", "cells", "is", "thought", "to", "be", "independent", "of", "CD40", "signaling", "[", "54", "]", "."], "sentence": "In support of this lack of effect , the differentiation of B-1 versus B-2 cells is thought to be independent of CD40 signaling [ 54 ] .", "event_mentions": [], "entity_mentions": [{"id": "T20", "text": "CD40", "entity_type": "Protein", "start": 21, "end": 21}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["B-1", "cells", "constitute", "the", "predominant", "lymphocyte", "population", "in", "the", "peritoneal", "and", "pleuropericardial", "cavities", ",", "while", "B-2", "cells", "are", "mainly", "found", "in", "the", "spleen", ",", "lymph", "node", ",", "and", "peripheral", "blood", "."], "sentence": "B-1 cells constitute the predominant lymphocyte population in the peritoneal and pleuropericardial cavities , while B-2 cells are mainly found in the spleen , lymph node , and peripheral blood .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["B-1", "cells", "produce", "the", "main", "source", "of", "IgM", "and", "IgA", "antibodies", "in", "serum", ",", "which", "are", "involved", "in", "T", "cell", "-", "independent", "responses", "to", "common", "microbial", "antigens", "."], "sentence": "B-1 cells produce the main source of IgM and IgA antibodies in serum , which are involved in T cell - independent responses to common microbial antigens .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["Importantly", ",", "B-1", "cells", "have", "the", "unique", "capacity", "to", "self", "replenish", "and", "are", "also", "predisposed", "to", "transformation", "[", "28", ",", "29", "]", "."], "sentence": "Importantly , B-1 cells have the unique capacity to self replenish and are also predisposed to transformation [ 28 , 29 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["Clonal", "expansion", "of", "B-1", "cells", "can", "be", "detected", "in", "aging", "mice", "above", "18", "mo", "of", "age", ",", "and", "B-1", "cells", "are", "thought", "to", "be", "the", "murine", "progenitor", "of", "B", "cell", "chronic", "lymphocytic", "leukemia", "[", "30", "]", "."], "sentence": "Clonal expansion of B-1 cells can be detected in aging mice above 18 mo of age , and B-1 cells are thought to be the murine progenitor of B cell chronic lymphocytic leukemia [ 30 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S19", "tokens": ["The", "data", "presented", "in", "this", "study", "indicate", "that", "although", "LMP1", "is", "expressed", "in", "all", "B", "lymphocytes", "in", "the", "transgenic", "mice", ",", "malignancy", "develops", "in", "this", "specific", "subset", "of", "B", "cells", "."], "sentence": "The data presented in this study indicate that although LMP1 is expressed in all B lymphocytes in the transgenic mice , malignancy develops in this specific subset of B cells .", "event_mentions": [{"id": "E5", "event_type": "Gene_expression", "trigger": {"text": "expressed", "start": 11, "end": 11}, "arguments": [{"entity_id": "T21", "text": "LMP1", "role": "Theme"}]}], "entity_mentions": [{"id": "T21", "text": "LMP1", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T101", "text": "expressed", "entity_type": "Gene_expression", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S20", "tokens": ["The", "elevated", "expression", "of", "LMP1", "in", "B-1a", "cells", "and", "the", "activation", "of", "specific", "pathways", "apparently", "induce", "malignant", "growth", "."], "sentence": "The elevated expression of LMP1 in B-1a cells and the activation of specific pathways apparently induce malignant growth .", "event_mentions": [{"id": "E6", "event_type": "Positive_regulation", "trigger": {"text": "elevated", "start": 1, "end": 1}, "arguments": [{"entity_id": "T103", "text": "expression", "role": "Theme"}]}, {"id": "E7", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 2, "end": 2}, "arguments": [{"entity_id": "T22", "text": "LMP1", "role": "Theme"}]}], "entity_mentions": [{"id": "T22", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T102", "text": "elevated", "entity_type": "Positive_regulation", "start": 1, "end": 1}, {"id": "T103", "text": "expression", "entity_type": "Gene_expression", "start": 2, "end": 2}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["These", "same", "pathways", "can", "also", "become", "sporadically", "activated", "in", "aged", "mice", "and", "also", "result", "in", "lymphoma", "development", "."], "sentence": "These same pathways can also become sporadically activated in aged mice and also result in lymphoma development .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S22", "tokens": ["This", "is", "similar", "to", "EBV", "-", "associated", "cancers", "in", "vivo", ",", "where", "pathways", "that", "are", "activated", "by", "LMP1", "are", "also", "activated", "in", "the", "less", "prevalent", "EBV", "-", "negative", "forms", "of", "the", "cancers", "[", "40", ",", "55-58", "]", "."], "sentence": "This is similar to EBV - associated cancers in vivo , where pathways that are activated by LMP1 are also activated in the less prevalent EBV - negative forms of the cancers [ 40 , 55-58 ] .", "event_mentions": [], "entity_mentions": [{"id": "T23", "text": "LMP1", "entity_type": "Protein", "start": 17, "end": 17}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S23", "tokens": ["Thus", ",", "the", "contribution", "of", "EBV", "and", "LMP1", "to", "tumor", "development", "is", "apparently", "the", "continuous", "activation", "of", "pathways", "that", "can", "also", "be", "sporadically", "activated", "and", "contribute", "to", "tumor", "development", "."], "sentence": "Thus , the contribution of EBV and LMP1 to tumor development is apparently the continuous activation of pathways that can also be sporadically activated and contribute to tumor development .", "event_mentions": [], "entity_mentions": [{"id": "T24", "text": "LMP1", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S24", "tokens": ["The", "lymphomas", "were", "marked", "by", "the", "upregulation", "of", "IL10", ",", "constitutive", "activation", "of", "Stat3", "signaling", ",", "and", "a", "requirement", "for", "activation", "of", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "pathways", "(", "Figures", "5", "and", "7", ")", "."], "sentence": "The lymphomas were marked by the upregulation of IL10 , constitutive activation of Stat3 signaling , and a requirement for activation of Akt , NFkappaB , and Stat3 pathways ( Figures 5 and 7 ) .", "event_mentions": [{"id": "E8", "event_type": "Positive_regulation", "trigger": {"text": "upregulation", "start": 6, "end": 6}, "arguments": [{"entity_id": "T25", "text": "IL10", "role": "Theme"}]}], "entity_mentions": [{"id": "T25", "text": "IL10", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T26", "text": "Stat3", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T27", "text": "Akt", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T28", "text": "Stat3", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T104", "text": "upregulation", "entity_type": "Positive_regulation", "start": 6, "end": 6}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S25", "tokens": ["Induction", "of", "IL10", "is", "associated", "with", "the", "transformation", "of", "B-1", "lymphomas", "in", "mice", "[", "59", ",", "60", "]", "and", "is", "frequently", "associated", "with", "EBV", "-", "positive", "B", "cell", "malignancies", "acting", "as", "a", "B", "cell", "growth", "factor", "[", "35-38", "]", "."], "sentence": "Induction of IL10 is associated with the transformation of B-1 lymphomas in mice [ 59 , 60 ] and is frequently associated with EBV - positive B cell malignancies acting as a B cell growth factor [ 35-38 ] .", "event_mentions": [{"id": "E9", "event_type": "Positive_regulation", "trigger": {"text": "Induction", "start": 0, "end": 0}, "arguments": [{"entity_id": "T29", "text": "IL10", "role": "Theme"}]}], "entity_mentions": [{"id": "T29", "text": "IL10", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T105", "text": "Induction", "entity_type": "Positive_regulation", "start": 0, "end": 0}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S26", "tokens": ["In", "addition", ",", "LMP1", "has", "been", "shown", "to", "stimulate", "IL10", "expression", "in", "Burkitt", "lymphoma", "cell", "lines", "[", "61", ",", "62", "]", "."], "sentence": "In addition , LMP1 has been shown to stimulate IL10 expression in Burkitt lymphoma cell lines [ 61 , 62 ] .", "event_mentions": [{"id": "E10", "event_type": "Positive_regulation", "trigger": {"text": "stimulate", "start": 8, "end": 8}, "arguments": [{"entity_id": "T107", "text": "expression", "role": "Theme"}, {"entity_id": "T30", "text": "LMP1", "role": "Cause"}]}, {"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 10, "end": 10}, "arguments": [{"entity_id": "T31", "text": "IL10", "role": "Theme"}]}], "entity_mentions": [{"id": "T30", "text": "LMP1", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T31", "text": "IL10", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T106", "text": "stimulate", "entity_type": "Positive_regulation", "start": 8, "end": 8}, {"id": "T107", "text": "expression", "entity_type": "Gene_expression", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S27", "tokens": ["This", "suggests", "that", "although", "Stat3", "is", "constitutively", "activated", "in", "the", "lymphoma", "cells", ",", "the", "induction", "of", "IL10", "may", "further", "enhance", "Stat3", "activation", "or", "may", "contribute", "to", "other", "IL10", "-", "responsive", "signaling", "pathways", "."], "sentence": "This suggests that although Stat3 is constitutively activated in the lymphoma cells , the induction of IL10 may further enhance Stat3 activation or may contribute to other IL10 - responsive signaling pathways .", "event_mentions": [{"id": "E12", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 7, "end": 7}, "arguments": [{"entity_id": "T32", "text": "Stat3", "role": "Theme"}]}, {"id": "E13", "event_type": "Positive_regulation", "trigger": {"text": "induction", "start": 14, "end": 14}, "arguments": [{"entity_id": "T33", "text": "IL10", "role": "Theme"}]}, {"id": "E14", "event_type": "Positive_regulation", "trigger": {"text": "enhance", "start": 19, "end": 19}, "arguments": [{"entity_id": "T111", "text": "activation", "role": "Theme"}, {"entity_id": "T109", "text": "induction", "role": "Cause"}]}, {"id": "E15", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 21, "end": 21}, "arguments": [{"entity_id": "T34", "text": "Stat3", "role": "Theme"}]}], "entity_mentions": [{"id": "T32", "text": "Stat3", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T33", "text": "IL10", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T34", "text": "Stat3", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T35", "text": "IL10", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T108", "text": "activated", "entity_type": "Positive_regulation", "start": 7, "end": 7}, {"id": "T109", "text": "induction", "entity_type": "Positive_regulation", "start": 14, "end": 14}, {"id": "T110", "text": "enhance", "entity_type": "Positive_regulation", "start": 19, "end": 19}, {"id": "T111", "text": "activation", "entity_type": "Positive_regulation", "start": 21, "end": 21}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S28", "tokens": ["LMP1", "activates", "both", "the", "canonical", "and", "non-canonical", "pathways", "of", "NFkappaB", "signaling", "[", "14", ",", "63-65", "]", ",", "and", "inhibition", "of", "NFkappaB", "blocked", "the", "survival", "of", "LMP1", "transgenic", "lymphocytes", "and", "LMP1", "-", "positive", "and", "-", "negative", "lymphoma", "cells", "."], "sentence": "LMP1 activates both the canonical and non-canonical pathways of NFkappaB signaling [ 14 , 63-65 ] , and inhibition of NFkappaB blocked the survival of LMP1 transgenic lymphocytes and LMP1 - positive and - negative lymphoma cells .", "event_mentions": [], "entity_mentions": [{"id": "T36", "text": "LMP1", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T37", "text": "LMP1", "entity_type": "Protein", "start": 25, "end": 25}, {"id": "T38", "text": "LMP1", "entity_type": "Protein", "start": 29, "end": 29}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S29", "tokens": ["NFkappaB", "and", "PI3K", "signaling", "are", "crucial", "for", "CD40", "-", "induced", "proliferation", ",", "and", "mice", "deficient", "for", "cRel", "or", "the", "p85", "regulatory", "subunit", "of", "PI3K", "are", "unresponsive", "to", "mitogenic", "stimuli", ",", "including", "CD40", "ligation", "[", "66-68", "]", "."], "sentence": "NFkappaB and PI3K signaling are crucial for CD40 - induced proliferation , and mice deficient for cRel or the p85 regulatory subunit of PI3K are unresponsive to mitogenic stimuli , including CD40 ligation [ 66-68 ] .", "event_mentions": [{"id": "E16", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 14, "end": 14}, "arguments": [{"entity_id": "T40", "text": "cRel", "role": "Theme"}]}, {"id": "E17", "event_type": "Negative_regulation", "trigger": {"text": "deficient", "start": 14, "end": 14}, "arguments": [{"entity_id": "T41", "text": "p85", "role": "Theme"}]}, {"id": "E18", "event_type": "Binding", "trigger": {"text": "ligation", "start": 32, "end": 32}, "arguments": [{"entity_id": "T42", "text": "CD40", "role": "Theme"}]}], "entity_mentions": [{"id": "T39", "text": "CD40", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T40", "text": "cRel", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T41", "text": "p85", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T42", "text": "CD40", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T112", "text": "deficient", "entity_type": "Negative_regulation", "start": 14, "end": 14}, {"id": "T113", "text": "ligation", "entity_type": "Binding", "start": 32, "end": 32}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S30", "tokens": ["We", "have", "previously", "shown", "that", "cRel", "is", "specifically", "activated", "in", "both", "wild-type", "and", "LMP1", "transgenic", "lymphomas", ",", "suggesting", "that", "activation", "of", "cRel", "is", "associated", "with", "B", "cell", "transformation", "[", "27", "]", "."], "sentence": "We have previously shown that cRel is specifically activated in both wild-type and LMP1 transgenic lymphomas , suggesting that activation of cRel is associated with B cell transformation [ 27 ] .", "event_mentions": [{"id": "E19", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 8, "end": 8}, "arguments": [{"entity_id": "T43", "text": "cRel", "role": "Theme"}]}, {"id": "E20", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 19, "end": 19}, "arguments": [{"entity_id": "T45", "text": "cRel", "role": "Theme"}]}], "entity_mentions": [{"id": "T43", "text": "cRel", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T44", "text": "LMP1", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T45", "text": "cRel", "entity_type": "Protein", "start": 21, "end": 21}, {"id": "T114", "text": "activated", "entity_type": "Positive_regulation", "start": 8, "end": 8}, {"id": "T115", "text": "activation", "entity_type": "Positive_regulation", "start": 19, "end": 19}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S31", "tokens": ["Our", "observations", "suggest", "that", "similar", "to", "CD40", "-", "induced", "proliferation", ",", "LMP1", "induces", "proliferation", "through", "PI3K", "-", "mediated", "activation", "of", "Akt", "and", "activation", "of", "NFkappaB", "components", "such", "as", "cRel", "."], "sentence": "Our observations suggest that similar to CD40 - induced proliferation , LMP1 induces proliferation through PI3K - mediated activation of Akt and activation of NFkappaB components such as cRel .", "event_mentions": [{"id": "E21", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 12, "end": 12}, "arguments": [{"entity_id": "T117", "text": "activation", "role": "Theme"}, {"entity_id": "T47", "text": "LMP1", "role": "Cause"}]}, {"id": "E23", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 12, "end": 12}, "arguments": [{"entity_id": "T118", "text": "activation", "role": "Theme"}, {"entity_id": "T47", "text": "LMP1", "role": "Cause"}]}, {"id": "E22", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 18, "end": 18}, "arguments": [{"entity_id": "T48", "text": "Akt", "role": "Theme"}]}, {"id": "E24", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 22, "end": 22}, "arguments": [{"entity_id": "T49", "text": "cRel", "role": "Theme"}]}], "entity_mentions": [{"id": "T46", "text": "CD40", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T47", "text": "LMP1", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T48", "text": "Akt", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T49", "text": "cRel", "entity_type": "Protein", "start": 28, "end": 28}, {"id": "T116", "text": "induces", "entity_type": "Positive_regulation", "start": 12, "end": 12}, {"id": "T117", "text": "activation", "entity_type": "Positive_regulation", "start": 18, "end": 18}, {"id": "T118", "text": "activation", "entity_type": "Positive_regulation", "start": 22, "end": 22}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S32", "tokens": ["CD40", "also", "induces", "downregulation", "of", "the", "cell", "cycle", "inhibitor", "p27", "through", "a", "PI3K", "-", "dependent", "manner", ",", "and", "the", "LMP1", "lymphoma", "cells", "also", "had", "decreased", "levels", "of", "p27", "with", "phosphorylation", "of", "Rb", "and", "increased", "Cdk2", "(", "Figure", "6C", ")", "[", "66", "]", "."], "sentence": "CD40 also induces downregulation of the cell cycle inhibitor p27 through a PI3K - dependent manner , and the LMP1 lymphoma cells also had decreased levels of p27 with phosphorylation of Rb and increased Cdk2 ( Figure 6C ) [ 66 ] .", "event_mentions": [{"id": "E25", "event_type": "Positive_regulation", "trigger": {"text": "induces", "start": 2, "end": 2}, "arguments": [{"entity_id": "T120", "text": "downregulation", "role": "Theme"}, {"entity_id": "T50", "text": "CD40", "role": "Cause"}]}, {"id": "E26", "event_type": "Negative_regulation", "trigger": {"text": "downregulation", "start": 3, "end": 3}, "arguments": [{"entity_id": "T51", "text": "p27", "role": "Theme"}]}, {"id": "E27", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 24, "end": 24}, "arguments": [{"entity_id": "T53", "text": "p27", "role": "Theme"}]}, {"id": "E28", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 29, "end": 29}, "arguments": [{"entity_id": "T54", "text": "Rb", "role": "Theme"}]}, {"id": "E29", "event_type": "Positive_regulation", "trigger": {"text": "increased", "start": 33, "end": 33}, "arguments": [{"entity_id": "T55", "text": "Cdk2", "role": "Theme"}]}], "entity_mentions": [{"id": "T50", "text": "CD40", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T51", "text": "p27", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T52", "text": "LMP1", "entity_type": "Protein", "start": 19, "end": 19}, {"id": "T53", "text": "p27", "entity_type": "Protein", "start": 27, "end": 27}, {"id": "T54", "text": "Rb", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T55", "text": "Cdk2", "entity_type": "Protein", "start": 34, "end": 34}, {"id": "T119", "text": "induces", "entity_type": "Positive_regulation", "start": 2, "end": 2}, {"id": "T120", "text": "downregulation", "entity_type": "Negative_regulation", "start": 3, "end": 3}, {"id": "T121", "text": "decreased", "entity_type": "Negative_regulation", "start": 24, "end": 24}, {"id": "T122", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 29, "end": 29}, {"id": "T123", "text": "increased", "entity_type": "Positive_regulation", "start": 33, "end": 33}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S33", "tokens": ["Although", "LMP1", "has", "been", "shown", "to", "deregulate", "the", "Rb", "pathway", "in", "epithelial", "cells", "[", "69", "]", ",", "to", "our", "knowledge", "this", "is", "the", "first", "demonstration", "of", "this", "property", "in", "B", "lymphocytes", "."], "sentence": "Although LMP1 has been shown to deregulate the Rb pathway in epithelial cells [ 69 ] , to our knowledge this is the first demonstration of this property in B lymphocytes .", "event_mentions": [], "entity_mentions": [{"id": "T56", "text": "LMP1", "entity_type": "Protein", "start": 1, "end": 1}, {"id": "T57", "text": "Rb", "entity_type": "Protein", "start": 8, "end": 8}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S34", "tokens": ["The", "requirement", "for", "Akt", "activation", "was", "confirmed", "by", "the", "striking", "inhibition", "of", "lymphoma", "viability", "by", "triciribine", ",", "an", "Akt", "inhibitor", "."], "sentence": "The requirement for Akt activation was confirmed by the striking inhibition of lymphoma viability by triciribine , an Akt inhibitor .", "event_mentions": [{"id": "E30", "event_type": "Positive_regulation", "trigger": {"text": "requirement", "start": 1, "end": 1}, "arguments": [{"entity_id": "T125", "text": "activation", "role": "Theme"}]}, {"id": "E31", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 4, "end": 4}, "arguments": [{"entity_id": "T58", "text": "Akt", "role": "Theme"}]}, {"id": "E32", "event_type": "Negative_regulation", "trigger": {"text": "inhibitor", "start": 19, "end": 19}, "arguments": [{"entity_id": "T59", "text": "Akt", "role": "Theme"}]}], "entity_mentions": [{"id": "T58", "text": "Akt", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T59", "text": "Akt", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T124", "text": "requirement", "entity_type": "Positive_regulation", "start": 1, "end": 1}, {"id": "T125", "text": "activation", "entity_type": "Positive_regulation", "start": 4, "end": 4}, {"id": "T126", "text": "inhibitor", "entity_type": "Negative_regulation", "start": 19, "end": 19}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S35", "tokens": ["However", ",", "the", "activated", "pAkt", "did", "not", "lead", "to", "phosphorylation", "and", "inactivation", "of", "the", "downstream", "target", "GSK3", "(", "Figure", "6A", ")", "."], "sentence": "However , the activated pAkt did not lead to phosphorylation and inactivation of the downstream target GSK3 ( Figure 6A ) .", "event_mentions": [{"id": "E33", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 3, "end": 3}, "arguments": [{"entity_id": "T60", "text": "pAkt", "role": "Theme"}]}, {"id": "E34", "event_type": "Positive_regulation", "trigger": {"text": "lead", "start": 7, "end": 7}, "arguments": [{"entity_id": "T129", "text": "phosphorylation", "role": "Theme"}, {"entity_id": "T127", "text": "activated", "role": "Cause"}]}, {"id": "E36", "event_type": "Positive_regulation", "trigger": {"text": "lead", "start": 7, "end": 7}, "arguments": [{"entity_id": "T130", "text": "inactivation", "role": "Theme"}, {"entity_id": "T127", "text": "activated", "role": "Cause"}]}, {"id": "E35", "event_type": "Phosphorylation", "trigger": {"text": "phosphorylation", "start": 9, "end": 9}, "arguments": [{"entity_id": "T61", "text": "GSK3", "role": "Theme"}]}, {"id": "E37", "event_type": "Negative_regulation", "trigger": {"text": "inactivation", "start": 11, "end": 11}, "arguments": [{"entity_id": "T61", "text": "GSK3", "role": "Theme"}]}], "entity_mentions": [{"id": "T60", "text": "pAkt", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T61", "text": "GSK3", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T127", "text": "activated", "entity_type": "Positive_regulation", "start": 3, "end": 3}, {"id": "T128", "text": "lead", "entity_type": "Positive_regulation", "start": 7, "end": 7}, {"id": "T129", "text": "phosphorylation", "entity_type": "Phosphorylation", "start": 9, "end": 9}, {"id": "T130", "text": "inactivation", "entity_type": "Negative_regulation", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "", "tokens": ["This", "effect", "has", "also", "been", "described", "in", "EBV", "-", "positive", "HD", "biopsies", "[", "40", "]", "."], "sentence": "This effect has also been described in EBV - positive HD biopsies [ 40 ] .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S37", "tokens": ["In", "contrast", ",", "rapamycin", ",", "U0126", ",", "and", "SB202190", "did", "not", "affect", "the", "survival", "of", "LMP1", "transgenic", "lymphocytes", "or", "the", "wild-type", "and", "LMP1", "transgenic", "lymphoma", "cells", "(", "Figure", "7A", ",", "7C", ",", "and", "7E", ")", "."], "sentence": "In contrast , rapamycin , U0126 , and SB202190 did not affect the survival of LMP1 transgenic lymphocytes or the wild-type and LMP1 transgenic lymphoma cells ( Figure 7A , 7C , and 7E ) .", "event_mentions": [], "entity_mentions": [{"id": "T62", "text": "LMP1", "entity_type": "Protein", "start": 15, "end": 15}, {"id": "T63", "text": "LMP1", "entity_type": "Protein", "start": 22, "end": 22}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S38", "tokens": ["This", "lack", "of", "effect", "by", "rapamycin", "confirmed", "the", "absence", "of", "activated", "p-mTOR", "levels", "(", "Figure", "6B", ")", "."], "sentence": "This lack of effect by rapamycin confirmed the absence of activated p-mTOR levels ( Figure 6B ) .", "event_mentions": [{"id": "E38", "event_type": "Negative_regulation", "trigger": {"text": "absence", "start": 8, "end": 8}, "arguments": [{"entity_id": "T132", "text": "activated", "role": "Theme"}]}, {"id": "E39", "event_type": "Positive_regulation", "trigger": {"text": "activated", "start": 10, "end": 10}, "arguments": [{"entity_id": "T64", "text": "p-mTOR", "role": "Theme"}]}], "entity_mentions": [{"id": "T64", "text": "p-mTOR", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T131", "text": "absence", "entity_type": "Negative_regulation", "start": 8, "end": 8}, {"id": "T132", "text": "activated", "entity_type": "Positive_regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S39", "tokens": ["These", "findings", "suggest", "that", "other", "Akt", "targets", "contribute", "to", "malignant", "progression", "."], "sentence": "These findings suggest that other Akt targets contribute to malignant progression .", "event_mentions": [], "entity_mentions": [{"id": "T65", "text": "Akt", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S40", "tokens": ["One", "key", "target", "is", "likely", "the", "inhibition", "of", "the", "Fox01", "transcription", "factors", "."], "sentence": "One key target is likely the inhibition of the Fox01 transcription factors .", "event_mentions": [{"id": "E41", "event_type": "Negative_regulation", "trigger": {"text": "inhibition", "start": 6, "end": 6}, "arguments": [{"entity_id": "T66", "text": "Fox01", "role": "Theme"}]}], "entity_mentions": [{"id": "T66", "text": "Fox01", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T133", "text": "target", "entity_type": "Regulation", "start": 2, "end": 2}, {"id": "T134", "text": "inhibition", "entity_type": "Negative_regulation", "start": 6, "end": 6}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S41", "tokens": ["Repression", "of", "the", "pro-apoptotic", "transcription", "factor", "FoxO1", "in", "a", "PI3K", "-", "dependent", "manner", "can", "inhibit", "expression", "of", "bcl6", ",", "a", "transcription", "factor", "necessary", "for", "GC", "formation", "[", "49", ",", "70", "]", "."], "sentence": "Repression of the pro-apoptotic transcription factor FoxO1 in a PI3K - dependent manner can inhibit expression of bcl6 , a transcription factor necessary for GC formation [ 49 , 70 ] .", "event_mentions": [{"id": "E42", "event_type": "Negative_regulation", "trigger": {"text": "Repression", "start": 0, "end": 0}, "arguments": [{"entity_id": "T67", "text": "FoxO1", "role": "Theme"}]}, {"id": "E43", "event_type": "Negative_regulation", "trigger": {"text": "inhibit", "start": 14, "end": 14}, "arguments": [{"entity_id": "T137", "text": "expression", "role": "Theme"}, {"entity_id": "T135", "text": "Repression", "role": "Cause"}]}, {"id": "E44", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 15, "end": 15}, "arguments": [{"entity_id": "T68", "text": "bcl6", "role": "Theme"}]}], "entity_mentions": [{"id": "T67", "text": "FoxO1", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T68", "text": "bcl6", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T135", "text": "Repression", "entity_type": "Negative_regulation", "start": 0, "end": 0}, {"id": "T136", "text": "inhibit", "entity_type": "Negative_regulation", "start": 14, "end": 14}, {"id": "T137", "text": "expression", "entity_type": "Gene_expression", "start": 15, "end": 15}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S42", "tokens": ["It", "has", "been", "shown", "that", "overstimulation", "of", "CD40", "signaling", "with", "agonistic", "antibodies", "inhibits", "GC", "formation", "[", "71", "]", "."], "sentence": "It has been shown that overstimulation of CD40 signaling with agonistic antibodies inhibits GC formation [ 71 ] .", "event_mentions": [], "entity_mentions": [{"id": "T69", "text": "CD40", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S43", "tokens": ["Similarly", ",", "due", "to", "mimicry", "of", "CD40", "signaling", ",", "transgenic", "LMP1", "mice", "are", "also", "defective", "in", "GC", "formation", "[", "23", ",", "49", "]", "."], "sentence": "Similarly , due to mimicry of CD40 signaling , transgenic LMP1 mice are also defective in GC formation [ 23 , 49 ] .", "event_mentions": [], "entity_mentions": [{"id": "T70", "text": "CD40", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T71", "text": "LMP1", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S44", "tokens": ["The", "constitutive", "signaling", "by", "LMP1", "likely", "blocks", "GC", "formation", "through", "downregulation", "of", "bcl6", "."], "sentence": "The constitutive signaling by LMP1 likely blocks GC formation through downregulation of bcl6 .", "event_mentions": [{"id": "E45", "event_type": "Negative_regulation", "trigger": {"text": "downregulation", "start": 10, "end": 10}, "arguments": [{"entity_id": "T73", "text": "bcl6", "role": "Theme"}]}], "entity_mentions": [{"id": "T72", "text": "LMP1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T73", "text": "bcl6", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T138", "text": "downregulation", "entity_type": "Negative_regulation", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S45", "tokens": ["Interestingly", ",", "clinical", "studies", "indicate", "that", "expression", "of", "LMP1", "and", "bcl6", "are", "mutually", "exclusive", "in", "non-HD", "and", "classical", "HD", "[", "72", ",", "73", "]", "."], "sentence": "Interestingly , clinical studies indicate that expression of LMP1 and bcl6 are mutually exclusive in non-HD and classical HD [ 72 , 73 ] .", "event_mentions": [{"id": "E46", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 6, "end": 6}, "arguments": [{"entity_id": "T74", "text": "LMP1", "role": "Theme"}]}, {"id": "E47", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 6, "end": 6}, "arguments": [{"entity_id": "T75", "text": "bcl6", "role": "Theme"}]}, {"id": "E48", "event_type": "Negative_regulation", "trigger": {"text": "exclusive", "start": 13, "end": 13}, "arguments": [{"entity_id": "T139", "text": "expression", "role": "Theme"}, {"entity_id": "T139", "text": "expression", "role": "Cause"}]}, {"id": "E49", "event_type": "Negative_regulation", "trigger": {"text": "exclusive", "start": 13, "end": 13}, "arguments": [{"entity_id": "T139", "text": "expression", "role": "Theme"}, {"entity_id": "T139", "text": "expression", "role": "Cause"}]}, {"id": "E50", "event_type": "Negative_regulation", "trigger": {"text": "exclusive", "start": 13, "end": 13}, "arguments": [{"entity_id": "T139", "text": "expression", "role": "Theme"}, {"entity_id": "T139", "text": "expression", "role": "Cause"}]}, {"id": "E51", "event_type": "Negative_regulation", "trigger": {"text": "exclusive", "start": 13, "end": 13}, "arguments": [{"entity_id": "T139", "text": "expression", "role": "Theme"}, {"entity_id": "T139", "text": "expression", "role": "Cause"}]}], "entity_mentions": [{"id": "T74", "text": "LMP1", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T75", "text": "bcl6", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T139", "text": "expression", "entity_type": "Gene_expression", "start": 6, "end": 6}, {"id": "T140", "text": "exclusive", "entity_type": "Negative_regulation", "start": 13, "end": 13}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S46", "tokens": ["Thus", ",", "the", "LMP1", "transgenic", "lymphomas", "mirror", "aspects", "of", "EBV", "-", "induced", "HD", "."], "sentence": "Thus , the LMP1 transgenic lymphomas mirror aspects of EBV - induced HD .", "event_mentions": [], "entity_mentions": [{"id": "T76", "text": "LMP1", "entity_type": "Protein", "start": 3, "end": 3}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S47", "tokens": ["Although", "the", "activation", "of", "Akt", "and", "the", "lack", "of", "Fox01", "in", "the", "lymphoma", "cells", "suggest", "that", "LMP1", "affects", "bcl6", "and", "GC", "formation", "through", "this", "pathway", ",", "regulation", "of", "other", "Forkhead", "targets", "involved", "in", "cell", "cycle", "progression", ",", "such", "as", "p27", "and", "CyclinD2", ",", "likely", "contribute", "to", "malignant", "transformation", "."], "sentence": "Although the activation of Akt and the lack of Fox01 in the lymphoma cells suggest that LMP1 affects bcl6 and GC formation through this pathway , regulation of other Forkhead targets involved in cell cycle progression , such as p27 and CyclinD2 , likely contribute to malignant transformation .", "event_mentions": [{"id": "E52", "event_type": "Positive_regulation", "trigger": {"text": "activation", "start": 2, "end": 2}, "arguments": [{"entity_id": "T77", "text": "Akt", "role": "Theme"}]}, {"id": "E53", "event_type": "Negative_regulation", "trigger": {"text": "lack", "start": 7, "end": 7}, "arguments": [{"entity_id": "T78", "text": "Fox01", "role": "Theme"}]}, {"id": "E54", "event_type": "Regulation", "trigger": {"text": "affects", "start": 17, "end": 17}, "arguments": [{"entity_id": "T80", "text": "bcl6", "role": "Theme"}, {"entity_id": "T144", "text": "pathway", "role": "Cause"}]}, {"id": "E55", "event_type": "Regulation", "trigger": {"text": "pathway", "start": 24, "end": 24}, "arguments": [{"entity_id": "T78", "text": "Fox01", "role": "Theme"}, {"entity_id": "T79", "text": "LMP1", "role": "Cause"}]}, {"id": "E56", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 26, "end": 26}, "arguments": [{"entity_id": "T81", "text": "p27", "role": "Theme"}]}, {"id": "E57", "event_type": "Regulation", "trigger": {"text": "regulation", "start": 26, "end": 26}, "arguments": [{"entity_id": "T82", "text": "CyclinD2", "role": "Theme"}]}], "entity_mentions": [{"id": "T77", "text": "Akt", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T78", "text": "Fox01", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T79", "text": "LMP1", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T80", "text": "bcl6", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T81", "text": "p27", "entity_type": "Protein", "start": 39, "end": 39}, {"id": "T82", "text": "CyclinD2", "entity_type": "Protein", "start": 41, "end": 41}, {"id": "T141", "text": "activation", "entity_type": "Positive_regulation", "start": 2, "end": 2}, {"id": "T142", "text": "lack", "entity_type": "Negative_regulation", "start": 7, "end": 7}, {"id": "T143", "text": "affects", "entity_type": "Regulation", "start": 17, "end": 17}, {"id": "T144", "text": "pathway", "entity_type": "Regulation", "start": 24, "end": 24}, {"id": "T145", "text": "regulation", "entity_type": "Regulation", "start": 26, "end": 26}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S48", "tokens": ["Indeed", ",", "loss", "of", "FoxO1", "expression", "in", "lymphoma", "cells", "correlated", "with", "a", "loss", "of", "p27", "(", "Figure", "6B", "and", "6C", ")", "."], "sentence": "Indeed , loss of FoxO1 expression in lymphoma cells correlated with a loss of p27 ( Figure 6B and 6C ) .", "event_mentions": [{"id": "E58", "event_type": "Negative_regulation", "trigger": {"text": "loss", "start": 2, "end": 2}, "arguments": [{"entity_id": "T147", "text": "expression", "role": "Theme"}]}, {"id": "E59", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 5, "end": 5}, "arguments": [{"entity_id": "T83", "text": "FoxO1", "role": "Theme"}]}, {"id": "E60", "event_type": "Positive_regulation", "trigger": {"text": "correlated", "start": 9, "end": 9}, "arguments": [{"entity_id": "T149", "text": "loss", "role": "Theme"}, {"entity_id": "T146", "text": "loss", "role": "Cause"}]}, {"id": "E61", "event_type": "Negative_regulation", "trigger": {"text": "loss", "start": 12, "end": 12}, "arguments": [{"entity_id": "T84", "text": "p27", "role": "Theme"}]}], "entity_mentions": [{"id": "T83", "text": "FoxO1", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T84", "text": "p27", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T146", "text": "loss", "entity_type": "Negative_regulation", "start": 2, "end": 2}, {"id": "T147", "text": "expression", "entity_type": "Gene_expression", "start": 5, "end": 5}, {"id": "T148", "text": "correlated", "entity_type": "Positive_regulation", "start": 9, "end": 9}, {"id": "T149", "text": "loss", "entity_type": "Negative_regulation", "start": 12, "end": 12}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S49", "tokens": ["CyclinD2", "has", "also", "been", "shown", "to", "be", "upregulated", "by", "LMP1", "through", "release", "of", "FoxO1", "-", "mediated", "repression", "[", "70", "]", "."], "sentence": "CyclinD2 has also been shown to be upregulated by LMP1 through release of FoxO1 - mediated repression [ 70 ] .", "event_mentions": [{"id": "E62", "event_type": "Positive_regulation", "trigger": {"text": "upregulated", "start": 7, "end": 7}, "arguments": [{"entity_id": "T85", "text": "CyclinD2", "role": "Theme"}]}], "entity_mentions": [{"id": "T85", "text": "CyclinD2", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T86", "text": "LMP1", "entity_type": "Protein", "start": 9, "end": 9}, {"id": "T87", "text": "FoxO1", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T150", "text": "upregulated", "entity_type": "Positive_regulation", "start": 7, "end": 7}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S50", "tokens": ["In", "summary", ",", "in", "this", "transgenic", "model", "of", "lymphomagenesis", ",", "LMP1", "promotes", "malignancy", "in", "B-1a", "cells", ",", "a", "population", "that", "is", "predisposed", "to", "clonal", "expansion", "with", "age", "."], "sentence": "In summary , in this transgenic model of lymphomagenesis , LMP1 promotes malignancy in B-1a cells , a population that is predisposed to clonal expansion with age .", "event_mentions": [], "entity_mentions": [{"id": "T88", "text": "LMP1", "entity_type": "Protein", "start": 10, "end": 10}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S51", "tokens": ["The", "malignant", "lymphocytes", "were", "distinguished", "by", "constitutively", "active", "Stat3", "signaling", ",", "decreased", "p27", ",", "and", "activated", "Akt", "and", "NFkappaB", "pathways", ",", "properties", "that", "are", "associated", "with", "promoting", "the", "growth", "and", "survival", "of", "B", "lymphocytes", "."], "sentence": "The malignant lymphocytes were distinguished by constitutively active Stat3 signaling , decreased p27 , and activated Akt and NFkappaB pathways , properties that are associated with promoting the growth and survival of B lymphocytes .", "event_mentions": [{"id": "E63", "event_type": "Negative_regulation", "trigger": {"text": "decreased", "start": 11, "end": 11}, "arguments": [{"entity_id": "T90", "text": "p27", "role": "Theme"}]}], "entity_mentions": [{"id": "T89", "text": "Stat3", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T90", "text": "p27", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T91", "text": "Akt", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T151", "text": "decreased", "entity_type": "Negative_regulation", "start": 11, "end": 11}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S52", "tokens": ["Importantly", ",", "Akt", ",", "NFkappaB", ",", "and", "Stat3", "pathways", "were", "critically", "required", "for", "the", "growth", "and", "survival", "of", "malignant", "lymphocytes", "as", "well", "as", "healthy", "LMP1", "transgenic", "lymphocytes", "."], "sentence": "Importantly , Akt , NFkappaB , and Stat3 pathways were critically required for the growth and survival of malignant lymphocytes as well as healthy LMP1 transgenic lymphocytes .", "event_mentions": [], "entity_mentions": [{"id": "T92", "text": "Akt", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T93", "text": "Stat3", "entity_type": "Protein", "start": 7, "end": 7}, {"id": "T94", "text": "LMP1", "entity_type": "Protein", "start": 24, "end": 24}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S53", "tokens": ["The", "growth", "of", "EBV-transformed", "lymphocytes", "also", "requires", "activation", "of", "NFkappaB", ",", "and", "these", "studies", "provide", "insight", "into", "how", "LMP1", "contributes", "to", "EBV", "-", "associated", "transformation", "."], "sentence": "The growth of EBV-transformed lymphocytes also requires activation of NFkappaB , and these studies provide insight into how LMP1 contributes to EBV - associated transformation .", "event_mentions": [], "entity_mentions": [{"id": "T95", "text": "LMP1", "entity_type": "Protein", "start": 18, "end": 18}]}
{"doc_id": "PMC-2065877-09-Discussion.txt", "sent_id": "S54", "tokens": ["The", "transgenic", "lymphomas", "mirror", "multiple", "aspects", "of", "EBV", "-", "induced", "tumors", "and", "suggest", "that", "in", "vivo", "these", "properties", "of", "LMP1", "are", "major", "factors", "in", "the", "development", "of", "cancer", "."], "sentence": "The transgenic lymphomas mirror multiple aspects of EBV - induced tumors and suggest that in vivo these properties of LMP1 are major factors in the development of cancer .", "event_mentions": [], "entity_mentions": [{"id": "T96", "text": "LMP1", "entity_type": "Protein", "start": 19, "end": 19}]}
